Instead of just tracking hard numbers, AI tools can systematically analyze years of transcripts to map out qualitative or "soft" guidance (e.g., "revenue will accelerate in H2"). This creates a picture of a management team's guidance style and credibility, a crucial but historically painstaking analysis to perform.

To manage investor expectations effectively, adopt a contrarian communication cadence. Only report good news (like a major deal) after it has officially closed, since many B2B deals fall through at the last minute. Conversely, report bad news as early as possible. This builds trust by preventing over-promising and demonstrating transparency when it matters most.

After facing backlash for over-promising on past releases, OpenAI has adopted a "low ball" communication strategy. The company intentionally underplayed the GPT-5.1 update to avoid being "crushed" by criticism when perceived improvements don't match the hype, letting positive user discoveries drive the narrative instead.

Analysts exhibit a predictable pattern: they issue overly optimistic long-term earnings forecasts to maintain good relationships with management, then gradually reduce them as the announcement nears. The final forecast is often slightly pessimistic, setting a low bar for companies to easily "beat," making the process a rigged game.

Post-IPO, credibility is a biotech's most valuable asset. Leaders should "under-promise and over-perform" by avoiding specific quarterly guidance for clinical milestones. Instead, use broader windows like "first half of the year" to build in flexibility, as clinical trials rarely run on a perfect schedule.

When questioned about discrepancies where a 24-week dose underperformed on the primary endpoint but was strong on secondary ones, the CEO avoided direct comparisons. Instead, he framed the results as a 'totality of evidence' supporting the drug's profile, a key communication tactic for presenting complex or imperfect data positively to investors and regulators.

To avoid making prohibited forward-looking statements to investors, a CEO advised his CMO to reframe answers. When asked about the future, respond with a story about a past event or success that demonstrates capability and strategy, effectively answering the question without speculation.

A CEO reveals the behind-the-scenes pressure of financial guidance: investors who own the stock often directly tell management teams to provide conservative public guidance to ensure they can beat analysts' estimates. This creates a challenging dynamic, separating operational reality from the manufactured expectations game required by the market.

Carles Reina instructs his team to forecast deals at the lowest possible value (e.g., forecast a potential $500k deal at $24k). This forces reps to build a much larger pipeline to meet their quotas and prevents inflated expectations with investors, creating a culture of under-promising and over-delivering.